LabGenius combines artificial intelligence, robotic automation and synthetic biology to evolve next-generation protein therapeutics.
LabGenius develops therapeutics of high value for diseases of unmet need. The company deploys machine intelligence to model the relationship between DNA sequence and protein function, while improving the predictive accuracy of these models through experimental lab data generated through its smart robotic platform.
- James Field
- Our CEO @jejfield comments on the appointment of Dr Edwin Moses as Chairman of LabGenius. Read more here:… https://t.co/DarnJaQxu1
- Pleased to welcome Dr Edwin Moses as Chairman of LabGenius. Read more about his appointment here:… https://t.co/txA0GmwI9P
- Delighted to announce the appointment of Edwin Moses as Chairman of LabGenius ‒ to have a Chairman of Edwin’s calib… https://t.co/t4SdmFwQpW